Connect with us

Technology

ADLM applauds the House Committee on Appropriations for approving $5 million for the CDC to improve pediatric medical testing

Published

on

WASHINGTON , June 10, 2026 /PRNewswire/ — The House Committee on Appropriations has approved the Fiscal Year (FY) 2027 Labor, Health and Human Services (HHS), Education, and Related Agencies Bill, which includes $5 million for the Centers for Disease Control and Prevention (CDC) to improve pediatric reference intervals. The development of better pediatric reference intervals is essential for children to get accurate diagnoses and effective care. The Association for Diagnostics & Laboratory Medicine (ADLM) commends the House Committee on Appropriations for supporting this initiative and urges legislators to pass this bill when it’s taken up by the entire Congress.

The current lack of accurate pediatric reference intervals is a serious issue that can lead to incorrect diagnoses and treatments for children. To correctly interpret pediatric lab test results, providers must evaluate results within the context of reference intervals, which are the range of normal test values expected in a healthy child. If a test result falls outside of the reference interval, this alerts the pediatrician that a child might have a condition requiring medical intervention. However, limited access to samples from healthy children has significantly hindered the establishment of accurate pediatric reference intervals. So while reference intervals for adults are generally reliable, there is considerable inconsistency in the ranges provided for young patients.

For many years, ADLM has led an ad hoc coalition of major healthcare groups that has worked to remedy this issue and that includes several pediatric organizations and medical device manufacturers. Fifty-four groups, including ADLM, the Children’s Hospital Association, the American Academy of Pediatrics, and others, have urged Congress to fund this initiative. This year in particular, the association has discussed the need for better pediatric reference intervals in a congressional briefing about children’s medical testing. ADLM has also visited individual congressional offices to discuss the need to address this critical issue. Now that this funding has been included in the FY2027 Labor, HHS, Education, and Related Agencies Bill, ADLM will advocate that Congress include it in any final budget package.

“We would like to thank the House Committee on Appropriations for including this essential funding in the FY2027 Labor, HHS, Education, and Related Agencies budget,” said ADLM President Dr. Paul J. Jannetto. “The development of better pediatric reference intervals will ultimately lead to the improvement of testing provided to our nation’s youngest and most vulnerable population. Federal involvement plays a crucial role in advancing this initiative.”

About the Association for Diagnostics & Laboratory Medicine (ADLM)
Dedicated to achieving better health for all through laboratory medicine, ADLM unites more than 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from 110 countries around the world. Our community is at the forefront of laboratory medicine’s diverse subdisciplines, including clinical chemistry, molecular diagnostics, mass spectrometry, clinical microbiology, and data science, and is comprised of individuals holding the spectrum of lab-related professional degrees, certifications, and credentials. Since 1948, ADLM has championed the advancement of laboratory medicine by fostering scientific collaboration, knowledge sharing, and the development of innovative solutions that enhance health outcomes. For more information, visit www.myadlm.org.

Christine DeLong
ADLM
Director, Editorial and Media Relations
(p) 202.835.8722
cdelong@myadlm.org

Bill Malone
ADLM
Senior Director, Strategic Communications
(p) 202.835.8756
bmalone@myadlm.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/adlm-applauds-the-house-committee-on-appropriations-for-approving-5-million-for-the-cdc-to-improve-pediatric-medical-testing-302796915.html

SOURCE Association for Diagnostics & Laboratory Medicine (ADLM)

Continue Reading

Technology

BONGUARD NATURALS ANNOUNCES RESOLUTION OF PATENT MATTER, REINFORCING PROTECTION OF NIXODINE® TECHNOLOGY

Published

on

By

Amicable Settlement Underscores Strength of Bonguard’s Intellectual Property Portfolio and Commitment to Protecting Innovation

PHOENIX, Sept. 8, 2026 /PRNewswire/ — Bonguard Naturals today announced the successful and amicable resolution of a patent matter protecting the intellectual property behind Nixodine®, a 6-methyl technology platform the company believes has the potential to fundamentally reshape its industry.

The resolution represents an important validation of Bonguard Naturals’ strategy to build, protect, and commercialize a robust intellectual property portfolio around a new generation of 6-methyl products. It also affirms the company’s commitment to defending those rights while fostering constructive relationships within the industry.

Ready Mix Naturals, LLC, owner of the patent portfolio covering innovative 6-methyl products sold under the Nixodine® brand, previously filed a federal patent action concerning certain products. The matter has now been resolved through a cooperative settlement that leaves the Nixodine® patent portfolio fully intact.

From the outset, LBC Products demonstrated a high degree of professionalism and compliance with Ready Mix’s requests. The parties worked constructively to reach an agreement that respects the underlying intellectual property while providing a clear, authorized path forward. Bonguard Naturals appreciates LBC’s cooperative approach throughout the process.

THE MESSAGE TO THE MARKETPLACE IS CLEAR:
THESE PATENTS MATTER. THEY ARE BEING PROTECTED. AND BONGUARD NATURALS REMAINS COMMITTED TO SAFEGUARDING THE INNOVATION BEHIND NIXODINE®.

Protecting Technology With the Potential to Define an Industry

The patents at the center of the matter form part of the intellectual property foundation supporting Nixodine®, an emerging 6-methyl product platform that Bonguard Naturals believes is poised to become an important force in the evolution of the industry.

As companies race to develop the next generation of products in this rapidly changing marketplace, proprietary technology — and the patents protecting it — can determine who ultimately leads a new category. Bonguard Naturals intends to be one of those leaders.

“We believe Nixodine® represents an extraordinary technological and commercial opportunity, and protecting the intellectual property behind it is one of our highest priorities,” said Rick Avila, co-founder of Bonguard Naturals. “These patents protect innovation that we believe has the potential to transform this industry. We invested in developing it, we invested in protecting it, and when necessary, we will invest in enforcing it.”

“This resolution should remove any doubt about how seriously we take our intellectual property,” Avila continued. “At the same time, we value constructive dialogue and are pleased that this matter was resolved in a spirit of cooperation.”

Building an Authorized Ecosystem

The agreement also highlights the commercial strength of the Nixodine® intellectual property strategy. It establishes a clear framework under which future participation in the 6-methyl space can occur through authorized channels that respect the underlying patents and brand standards.

Bonguard Naturals is not merely building a brand. It is building an intellectual-property-protected commercial ecosystem around technology it believes could help define the next era of the industry.

Four U.S. Patents — And A Broader Intellectual Property Portfolio

The matter involved U.S. Patent Nos. 11,964,958; 12,358,888; 12,358,889; and 12,497,381.

The broader portfolio also encompasses certain related divisional, continuations, continuations-in-part, reissues and reexaminations. Together, these intellectual property rights form an increasingly important protective framework around Nixodine® technology.

A Clear Signal to the Marketplace

Bonguard Naturals intends to continue monitoring the marketplace for potential infringement and taking appropriate action to protect its intellectual property when necessary.

For manufacturers, distributors and brands operating in the 6-methyl space, this resolution establishes an important precedent: the company is attentive to the market, understands the value of its patents, and is prepared to protect them — preferably through constructive engagement whenever possible.

“In emerging industries, there is often a period where companies assume new technology is simply available for anyone to copy,” Avila said. “That is not the case here. We have built meaningful intellectual property around Nixodine®, and we intend to defend it. We also welcome those who wish to participate through authorized channels.”

As Nixodine® moves toward broader commercialization, Bonguard Naturals intends to continue investing in innovation, expanding its intellectual property position, and protecting the technology it believes can help transform the industry.

About Bonguard Naturals

Bonguard Naturals is the company behind Nixodine®, an innovative 6-methyl product platform supported by a growing intellectual property portfolio. The company is focused on developing, protecting and commercializing proprietary technology while building an authorized commercial ecosystem designed to safeguard innovation, product integrity and the Nixodine® brand.

View original content to download multimedia:https://www.prnewswire.com/news-releases/bonguard-naturals-announces-resolution-of-patent-matter-reinforcing-protection-of-nixodine-technology-302872684.html

SOURCE Bonguard Naturals

Continue Reading

Technology

Trading Technologies and FairXchange Partner to Deliver Independent Execution Analytics for Institutional FX

Published

on

By

Adds independent liquidity and execution analytics to TT’s institutional FX execution venue

LONDON and CHICAGO, Sept. 8, 2026 /PRNewswire/ — Trading Technologies International, Inc. (TT), a global capital markets technology provider, and FairXchange, part of United Fintech and a leading data science firm specializing in independent microstructural FX analytics, today announced the integration of FairXchange Horizon into TT’s institutional foreign exchange (FX) offering.

With FairXchange Horizon’s market-leading analytics embedded directly into the TT® platform, clients trading FX through TT can access independent execution analytics across spot FX, forwards, non-deliverable forwards (NDFs) and swaps. FairXchange Horizon’s liquidity and algo analytics enable clients to measure execution quality, analyze flow and liquidity-provider performance, and optimize counterparty relationships.

The partnership meets the need for greater execution transparency and liquidity optimization among institutional FX participants, combining TT’s execution capabilities with FairXchange’s independent analytics to provide a complete FX trading workflow.

Tom Robinson, Partner, United Fintech, said: “This partnership addresses a clear need within institutional FX trading for best-in-class analytics to manage liquidity relationships and execution quality. Horizon delivers this by providing independent insight into flow, pricing and counterparty activity across the full FX execution workflow.”

Tomo Tokuyama, EVP, Managing Director, FX at Trading Technologies, said: “We will give clients access to best-in-class technology across every aspect of the trading workflow. FairXchange Horizon complements TT’s institutional FX execution capabilities by providing independent, data-driven analytics that help clients evaluate execution quality, strengthen liquidity relationships and make more informed trading decisions. It’s another example of TT delivering an open, multi-asset platform built around our clients’ needs.”

TT FX unifies OTC and listed markets within a single, high-performance workflow, with liquidity from bank and non-bank liquidity providers alongside primary FX venues and electronic communication networks (ECNs). Clients can trade FX alongside futures and precious metals through a single, unified interface within TT’s market-leading execution management system (EMS), either directly or via bank algorithms.

About FairXchange and United Fintech
FairXchange, part of United Fintech, is a data science firm specializing in microstructural analysis of financial markets. Its mission is to bring clarity and transparency to execution performance through independent data, facilitating constructive, data-driven conversations between market participants.

Founded in 2020, United Fintech is an industry-neutral ecosystem connecting financial institutions with best-in-class fintech solutions. Through selective acquisitions, deep integration, and a shared infrastructure, United Fintech streamlines procurement and accelerates the adoption of new technology across global finance.

Backed by strategic investors including Citi, Danske Bank, BNP Paribas, Standard Chartered, and Barclays, United Fintech combines capital markets expertise with technology leadership to help financial institutions modernize their operations and drive sustainable growth.

United Fintech has 10 offices worldwide, including in London, New York, Copenhagen, Singapore and UAE.

For more information, visit www.unitedfintech.com.

About Trading Technologies
Trading Technologies (www.tradingtechnologies.com), owned by Thoma Bravo and 7RIDGE, is a global capital markets platform services company providing market-leading technology for the end-to-end trading operations of Tier 1 banks, brokerages, money managers, hedge funds, proprietary traders, Commodity Trading Advisors (CTAs), commercial hedgers and risk managers. With its roots in listed derivatives, the Software-as-a-Service (SaaS) company delivers “multi-X” solutions across asset classes, functions, workflows and geographies. The TT platform ecosystem features trade execution across futures, options, fixed income, foreign exchange (FX) and cryptocurrencies, augmented by solutions for data and margin analytics, trade surveillance, clearing and post-trade allocation.

View original content to download multimedia:https://www.prnewswire.com/news-releases/trading-technologies-and-fairxchange-partner-to-deliver-independent-execution-analytics-for-institutional-fx-302872696.html

SOURCE Trading Technologies

Continue Reading

Technology

oneworld Partners with Popular App Timeshifter to Help Round the World Travellers Beat Jet Lag

Published

on

By

Science-based, personalised jet lag plans provided for every Round the World journey purchased on oneworld.com

FORT WORTH, Texas, Sept. 8, 2026 /PRNewswire/ — The oneworld® Alliance is helping customers adjust to new time zones faster and lose fewer days to jet lag on Round the World journeys through a new partnership with Timeshifter – the world’s most-downloaded jet lag app, with more than 1.7 million users.

Effective immediately, customers purchasing Round the World trips on oneworld.com will receive a complimentary Timeshifter subscription that covers their entire itinerary, considering every flight and time zone shift from departure to final return.

“Our partnership with Timeshifter will help Round the World customers arrive ready to enjoy each new destination by supporting better sleep and faster adjustment to new time zones,” said Roger Blackburn, vice president of Loyalty and Commercial for oneworld, in remarks from the stage at the oneworld Loyalty Summit in Dallas/Ft. Worth. “Jet lag has a significant impact on health and wellbeing. This new partnership provides oneworld an opportunity to do what we do best: deliver a premium, elevated experience at every opportunity along the journey.”

Timeshifter is based on the latest circadian science, and advice is personalised to each customer’s flight itinerary, typical sleep pattern, chronotype and personal preferences.

“Timeshifter is trusted by astronauts, Formula One teams and professional athletes, and we are excited to be working with oneworld to provide this same circadian science to oneworld’s customers, improving their health and enjoyment when they cross time zones,” said Mickey Beyer-Clausen, CEO of Timeshifter. “Air travel has optimised nearly every part of flying except for what crossing multiple time zones can do to the traveller – a gap our partnership with oneworld will help to close.” 

What is jet lag?

Jet lag is not a sleep problem but a temporary misalignment between a person’s internal circadian clock and local time at their destination. The circadian clock keeps sleep, alertness, digestion, immune function, and dozens of other systems, synchronized to a 24-hour day, and takes its cues from light and darkness.

When travellers cross several time zones, the light-dark cycle shifts by hours, while the circadian clock moves only about an hour a day on its own. The only way to adjust to new time zones quickly is by timing light exposure and light avoidance precisely. If the timing is wrong, it will make jet lag worse.

“This is just the latest example of the creative ways we are engaging with premium partners who bring true value and an elevated experience to oneworld customers,” said Ole Orvér, CEO of oneworld.

About Timeshifter

Timeshifter is the global leader in circadian technology, translating circadian science into breakthrough products and solutions that improve human performance, safety, and health. In 2018, Timeshifter made jet lag history with its first product – now the most-downloaded jet lag app in the world. Building on this success, Timeshifter introduced a groundbreaking app to help shift workers improve their sleep, safety, health, and quality of life. Timeshifter’s concierge services support astronauts, NBA players, Formula 1 drivers and Olympic athletes perform at their best.

Round the World with oneworld:

oneworld offers the most comprehensive alliance Round the World product across its network of nearly 1,000 destinations. On average, customers book seven stops, with trips lasting for around three months. More information about oneworld’s Round the World fares, including destination inspiration and how to book is available at oneworld.com. 

About oneworld

oneworld brings together 15 world-class airlines – Alaska Airlines/Hawaiian Airlines, American Airlines, British Airways, Cathay Pacific, Fiji Airways, Finnair, Iberia, Japan Airlines, Malaysia Airlines, Oman Air, Qantas, Qatar Airways, Royal Air Maroc, Royal Jordanian and SriLankan Airlines to nearly 1,000 destinations. oneworld member airlines work together to consistently deliver a superior, consistent travel experience, with special rewards and privileges for its frequent flyers, including earning and redeeming miles and points across the entire alliance network, access to airport lounges, priority check in, boarding, extra baggage allowances and more. Learn more about the oneworld Alliance at oneworld.com.

Follow us on FacebookInstagram, X and LinkedIn.

Contact:
press@oneworld.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/oneworld-partners-with-popular-app-timeshifter-to-help-round-the-world-travellers-beat-jet-lag-302872705.html

SOURCE oneworld Management Company, Inc

Continue Reading

Trending